Quarterly Result16 May 2026, 05:40 pm
Valiant Organics: Audited Results for FY26 Approved
AI Summary
Valiant Organics Ltd. has announced the approval of audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, as per SEBI regulations. The board also approved the identification of the Pharma Business as an additional reportable segment. Re-appointments of the Cost Auditor and Internal Auditor for FY 2026-27 were also approved. The board meeting concluded on May 16, 2026.
Key Highlights
- Audited standalone and consolidated financial results for FY26 approved.
- Pharma Business identified as an additional reportable segment.
- Ketki D. Visariya re-appointed as Cost Auditor for FY 2026-27.
- M/s. Manish Modi & Associates re-appointed as Internal Auditor for FY 2026-27.
- Auditor's report indicates an unmodified opinion on the financial results.
Price Impact
More from VALIANTORG